Answer
May 22, 2025 - 09:48 AM
The dosage strength of the delayed-release tablet is 35 mg. This specific dosage is designed to balance efficacy with safety, minimizing the risk of side effects while ensuring therapeutic benefits.
Do you have the same question? Follow this Question
May 22, 2025 - 09:48 AM
View all Atelvia (Risedronate) Delayed Release Questions & Answers